MAG
MRK icon

Mayfair Advisory Group’s Merck MRK Stock Holding History

Mayfair Advisory Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$456K Sell
3,477
-490
-12% -$57.4K 0.14% 114
2026
Q1 		$477K Sell
3,967
-314
-7% -$36.3K 0.17% 102
2025
Q4 		$456K Sell
4,281
-2
-0% -$188 0.18% 101
2025
Q3 		$359K Buy
4,283
+124
+3% +$10.2K 0.15% 117
2025
Q2 		$336K Sell
4,159
-21
-0.5% -$1.67K 0.16% 119
2025
Q1 		$375K Sell
4,180
-1,209
-22% -$113K 0.22% 92
2024
Q4 		$536K Buy
5,389
+464
+9% +$47.8K 0.32% 62
2024
Q3 		$541K Buy
4,925
+25
+0.5% +$2.97K 0.34% 54
2024
Q2 		$626K Sell
4,900
-92
-2% -$11.9K 0.42% 45
2024
Q1 		$659K Buy
4,992
+148
+3% +$18.2K 0.48% 41
2023
Q4 		$549K Buy
4,844
+200
+4% +$20.8K 0.47% 42
2023
Q3 		$481K Buy
4,644
+550
+13% +$59.3K 0.46% 48
2023
Q2 		$446K Hold
4,094
– – 0.45% 52
2023
Q1 		$472K Hold
4,094
– – 0.51% 48
2022
Q4 		$452K Sell
4,094
-241
-6% -$24.6K 0.58% 47
2022
Q3 		$380K Buy
4,335
+777
+22% +$69.4K 0.54% 50
2022
Q2 		$318K Buy
3,558
+121
+4% +$10.7K 0.42% 71
2022
Q1 		$287K Buy
3,437
+348
+11% +$27.4K 0.37% 65
2021
Q4 		$244K Buy
3,089
+14
+0.5% +$1.11K 0.32% 80
2021
Q3 		$256K Buy
3,075
+250
+9% +$19K 0.39% 70
2021
Q2 		$220K Sell
2,825
-83
-3% -$6.17K 0.35% 83
2021
Q1 		$214K Sell
2,908
-755
-21% -$55.7K 0.38% 80
2020
Q4 		$286K Sell
3,663
-17
-0.5% -$1.3K 0.56% 49
2020
Q3 		$291K Buy
3,680
+599
+19% +$46.9K 0.75% 34
2020
Q2 		$227K Buy
+3,081
New +$232K 0.73% 37

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mayfair Advisory Group's MRK Position: Q2 2026 in Review

Mayfair Advisory Group reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $57.4K and leaving 3,477 shares worth $456K. The position accounts for 0.14% of the portfolio, ranked #114.

Mayfair Advisory Group first reported a position in MRK in Q2 2020 and has held it in 25 quarters since. The position peaked at $659K in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mayfair Advisory Group held 3,477 shares of Merck worth $456K as of Q2 2026.
  • Mayfair Advisory Group sold 490 Merck shares in Q2 2026, an estimated $57.4K.
  • Merck made up 0.14% of Mayfair Advisory Group's portfolio in Q2 2026, its #114 holding.
  • Mayfair Advisory Group first reported a position in Merck in Q2 2020 and has held it in 25 quarters since.
  • Mayfair Advisory Group's Merck position peaked at $659K in Q1 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mayfair Advisory Group's 13F filing for Q2 2026, filed 11 Aug 2026.